Inventor

JUHL KARSTEN

DK54 patents

⚠️ This page may combine multiple inventors who share the name “JUHL KARSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JUHL KARSTEN

H LUNDBECK AS

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

Macrocycles as PDE1 inhibitors

1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors

PDE9 inhibitors with imidazo triazinone backbone

PDE9 inhibitors with imidazo triazinone backbone

PDE9 inhibitors with imidazo triazinone backbone

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Antibodies specific for hyperphosphorylated tau and methods of use

Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Imidazopyrazinones as PDE1 inhibitors

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors

1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors

Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors

Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

Imidazopyrazinones as PDE1 inhibitors

1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors

Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors

Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors

2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines

Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines

Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines

2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer&#39;s disease

2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

LUNDBECK & CO AS H

2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer&#39;s disease

2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS

Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS

2-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence

2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIs

KHANZHIN NIKOLAY

Isoquinolinone derivatives as NK3 antagonists

Isoquinolinone derivatives as NK3 antagonists

Isoquinolinone derivatives as NK3 antagonists

Pyridone derivatives as NK3 antagonists

Isoquinolinone derivatives as NK3 antagonists

KEHLER JAN

2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI

[2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

SIMONSEN KLAUS BAEK

Isoquinolinone derivatives as NK3 antagonists

2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease

2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease